Stockscreener 앱 받기
77.81
1.80%
-1.43
전일 마감가:
$79.24
열려 있는:
$79.39
하루 거래량:
5.17M
Relative Volume:
0.73
시가총액:
$98.69B
수익:
$393.94B
순이익/손실:
$428.00M
주가수익비율:
203.37
EPS:
0.3826
순현금흐름:
$6.29B
1주 성능:
-1.49%
1개월 성능:
-2.32%
6개월 성능:
+29.60%
1년 성능:
+41.24%
1일 변동 폭
$77.75
$79.74
1주일 범위
$76.50
$81.72
52주 변동 폭
$43.56
$85.15
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
CVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
77.81 | 100.59B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
321.86 | 301.21B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
325.83 | 72.96B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
269.66 | 72.36B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
237.12 | 28.47B | 123.11B | 1.58B | 2.44B | 13.03 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-08-18 | 업그레이드 | UBS | Neutral → Buy |
| 2025-08-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
Hedge Fund Sells $25.6 Million in Paramount Group Stock as Rithm's $1.6 Billion Deal Looms - The Motley Fool
Can CVS Health Corporation (Common Stock) (CVS0) stock double in coming years2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Can CVS Health Corporation (Common Stock) (CVS0) stock deliver consistent EPS growthTake Profit & Technical Pattern Based Buy Signals - newser.com
TD Cowen Lifts CVS Health Corporation (CVS) Price Target amid Record Q3 Revenue - Insider Monkey
What the charts say about CVS Health Corporation todayQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
How CVS Health Corporation (Common Stock) (CVS0) stock reacts to monetary easingMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
Will CVS Health Corporation (CVS) stock beat revenue estimatesWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com
CVS Reaches Deal In 'Non-Drowsy' Labeling Class Action - Law360
Should you wait for a breakout in CVS Health CorporationJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Is CVS Health Corporation stock supported by strong fundamentalsWeekly Profit Summary & Daily Risk Controlled Trade Plans - newser.com
CVS Health (CVS) Analyst Rating: Wells Fargo Lowers Price Target | CVS Stock News - GuruFocus
The Bull Case For CVS Health (CVS) Could Change Following Raised Earnings Guidance and Key Segment Strength - Yahoo Finance
Stock of the weekCVS Health Corp (13.11.2025) - XTB.com
Is CVS Health Corporation (CVS) stock a contrarian opportunityJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
LLY: Eli Lilly Stock Climbs After Exiting CVS Drug Plan - Yahoo Finance
CVS Health Better See Its General Practitioner For a Check Up - TheStreet Pro
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. - AOL.com
Eli Lilly drops CVS drug plan for staff after Novo obesity deal, Bloomberg News reports - Reuters
3 Stocks That Have Made Epic Comebacks in 2025 - AOL.com
Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch - Benzinga
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Eli Lilly Stock Jumps Premarket On Dumping CVS Drug Plan After Wegovy Snub — Retail Calls It A Pushback Against PBM Power - MSN
Eli Lilly Removes CVS from Employee Drug Plan Following Weight-Loss Drug Snub - Meyka
Eli Lilly drops CVS as employee drug plan after weight-loss drug snubreport - Investing.com
Lilly Drops CVS Drug Plan for Workers After Novo Deal - Bloomberg.com
Lilly Drops CVS Drug Plan for Workers After Novo Obesity Deal - Bloomberg.com
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday - AOL.com
CVS Health Lifts Adjusted EPS Outlook: What's Driving It? - Yahoo Finance
CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap. - AOL.com
Pete Buttigieg Slams Trump's 'Bad Deal' On Health Insurance, Cites CBO Estimate Of 10% Premium Hikes: 'Losing On The Economy' - Benzinga
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December - Benzinga
Judge says CVS Pharmacy must face class action lawsuit alleging it unlawfully tracked health data of online users - Class Action Lawsuits
CVS Health (NYSE: CVS) to outline 2025–2026 guidance at Investor Day with webcast - Stock Titan
How the Changing Story Could Impact CVS Health’s Valuation and Growth Prospects - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Raises Position in CVS Health Corporation $CVS - MarketBeat
Metis Global Partners LLC Trims Holdings in CVS Health Corporation $CVS - MarketBeat
Savant Capital LLC Has $3.81 Million Position in CVS Health Corporation $CVS - MarketBeat
How CVS Health Corporation stock performs in rate cut cyclesJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earningsDividend Hike & Safe Capital Growth Plans - newser.com
Rite Aid Patient Files Acquired by CVS - SNJ Today
CVS Health’s CFO Is Leaving as Pharmacy Chain Faces Activist Investor - MSN
Will CVS Health Corporation bounce back from current supportRisk Management & Reliable Entry Point Trade Alerts - newser.com
5,999 Shares in CVS Health Corporation $CVS Purchased by Efficient Advisors LLC - MarketBeat
CVS Health Corporation $CVS Shares Bought by Aviva PLC - MarketBeat
CVS Health Corporation $CVS Shares Acquired by AE Wealth Management LLC - MarketBeat
S&T Bank PA Cuts Stake in CVS Health Corporation $CVS - MarketBeat
Twin Capital Management Inc. Purchases 10,795 Shares of CVS Health Corporation $CVS - MarketBeat
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.75%
0.16%
자본화:
|
볼륨(24시간):